中证港股通化学药综合指数报3339.75点，前十大权重包含恒瑞医药等

Core Points - The CSI Hong Kong Stock Connect Pharmaceutical Index has shown significant growth, with a 12.87% increase over the past month, 43.55% over the past three months, and a 67.00% increase year-to-date [1] Group 1: Index Performance - The CSI Hong Kong Stock Connect Pharmaceutical Index is currently at 3339.75 points [1] - The index is based on a sample of securities classified according to the China Securities Index industry classification standards [1] Group 2: Index Composition - The top ten weighted stocks in the index include China Biologic Products (18.53%), BeiGene (13.57%), and CSPC Pharmaceutical Group (13.41%) [1] - The index is composed entirely of stocks listed on the Hong Kong Stock Exchange, with 100.00% market share [1] - The index's holdings are primarily in drug formulations (95.80%) and raw materials (4.20%) [1] Group 3: Index Adjustment - The index samples are adjusted biannually, with adjustments occurring on the next trading day after the second Friday of June and December [2] - Weight factors are generally fixed until the next scheduled adjustment, unless there are special events affecting the index [2]